Verisk Analytics announced a $1.5 billion notes offering to finance its acquisition of AccuLynx, pending standard closing conditions.
Quiver AI Summary
Verisk Analytics, Inc. has announced the pricing of a $750 million offering of 4.500% Senior Notes due 2030 and $750 million of 5.125% Senior Notes due 2036, with the closing expected on August 21, 2025, subject to certain conditions. The funds raised will be utilized, alongside existing cash and a new loan facility, to finance the $2.35 billion acquisition of AccuLynx. The offering is not contingent on the acquisition's completion, which will occur later. Goldman Sachs, BofA Securities, and Wells Fargo are managing the offering, which is being conducted under an effective registration statement. Verisk is a key player in data analytics for the global insurance industry, aiding in various operational and risk management strategies.
Potential Positives
- Verisk is raising $1.5 billion through the offering of Senior Notes, enhancing its financial capacity to facilitate strategic acquisitions.
- The proceeds will be used to finance the $2.35 billion acquisition of AccuLynx, indicating a significant investment in expanding Verisk's capabilities and market position.
- The offering is not contingent upon the completion of the acquisition, providing financial flexibility and reducing risk.
- Verisk's growth strategy appears robust, as the acquisition of AccuLynx aligns with its goal of strengthening its position as a data analytics and technology partner in the insurance industry.
Potential Negatives
- The company is taking on significant debt, issuing $1.5 billion in senior notes, which may raise concerns about financial leverage and long-term solvency.
- The use of debt financing for a large acquisition (approximately $2.35 billion) could indicate potential liquidity issues or reliance on borrowed funds to sustain growth strategies.
- The fact that the sale of the notes is not conditioned upon the closing of the acquisition may imply uncertainty regarding the consummation of the deal and the company's financial health.
FAQ
What are the new Senior Notes issued by Verisk?
Verisk announced the pricing of $750 million of 4.500% Senior Notes due 2030 and $750 million of 5.125% Senior Notes due 2036.
How will Verisk use the proceeds from the Senior Notes?
The proceeds will finance the approximately $2.35 billion purchase price for the acquisition of AccuLynx.
When is the expected closing date for the offering?
The closing of the offering is expected to occur on August 21, 2025, pending customary closing conditions.
Who are the joint book-running managers for the offering?
The joint book-running managers are Goldman Sachs & Co. LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC.
Are the Notes offered contingent upon the Acquisition?
No, the sale of the Notes is not conditioned upon the consummation of the Acquisition.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$VRSK Insider Trading Activity
$VRSK insiders have traded $VRSK stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $VRSK stock by insiders over the last 6 months:
- NICHOLAS DAFFAN (Chief Information Officer) has made 0 purchases and 3 sales selling 16,258 shares for an estimated $4,828,546.
- SAMUEL G LISS has made 0 purchases and 2 sales selling 11,656 shares for an estimated $3,648,994.
- DAVID J. GROVER (Chief Accounting Officer) sold 5,705 shares for an estimated $1,755,314
- LEE SHAVEL (Chief Executive Officer) has made 0 purchases and 4 sales selling 4,400 shares for an estimated $1,305,744.
- BRUCE EDWARD HANSEN has made 0 purchases and 3 sales selling 3,537 shares for an estimated $1,033,004.
- ELIZABETH MANN (Chief Financial Officer) has made 0 purchases and 5 sales selling 1,500 shares for an estimated $449,448.
- KATHY CARD BECKLES (Chief Legal Officer) sold 326 shares for an estimated $98,080
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRSK Hedge Fund Activity
We have seen 474 institutional investors add shares of $VRSK stock to their portfolio, and 456 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AMERIPRISE FINANCIAL INC added 1,221,798 shares (+631.0%) to their portfolio in Q1 2025, for an estimated $363,631,520
- GAMMA INVESTING LLC removed 1,199,511 shares (-99.6%) from their portfolio in Q2 2025, for an estimated $373,647,676
- INVESCO LTD. added 596,225 shares (+36.0%) to their portfolio in Q1 2025, for an estimated $177,448,484
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 434,053 shares (+35.6%) to their portfolio in Q1 2025, for an estimated $129,182,853
- JPMORGAN CHASE & CO added 393,668 shares (+52.7%) to their portfolio in Q1 2025, for an estimated $117,163,470
- GOLDMAN SACHS GROUP INC added 377,614 shares (+49.5%) to their portfolio in Q1 2025, for an estimated $112,385,478
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 373,712 shares (-26.2%) from their portfolio in Q1 2025, for an estimated $111,224,165
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$VRSK Analyst Ratings
Wall Street analysts have issued reports on $VRSK in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 05/08/2025
- B of A Securities issued a "Underperform" rating on 04/10/2025
- Wells Fargo issued a "Overweight" rating on 02/27/2025
To track analyst ratings and price targets for $VRSK, check out Quiver Quantitative's $VRSK forecast page.
$VRSK Price Targets
Multiple analysts have issued price targets for $VRSK recently. We have seen 7 analysts offer price targets for $VRSK in the last 6 months, with a median target of $315.0.
Here are some recent targets:
- C. Gregory Peters from Raymond James set a target price of $315.0 on 08/04/2025
- Toni Kaplan from Morgan Stanley set a target price of $319.0 on 07/31/2025
- Alex Kramm from UBS set a target price of $300.0 on 07/31/2025
- Jeffrey Meuler from Baird set a target price of $335.0 on 05/08/2025
- Joshua Dennerlein from B of A Securities set a target price of $280.0 on 04/10/2025
- Jason Haas from Wells Fargo set a target price of $321.0 on 02/27/2025
- Jeffrey Silber from BMO Capital set a target price of $297.0 on 02/27/2025
Full Release
JERSEY CITY, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Verisk Analytics, Inc. (Nasdaq: VRSK) (“Verisk” or the “Company”), a leading global data analytics and technology provider, today announced the pricing of an offering of $750 million of 4.500% Senior Notes due 2030 (the “2030 Notes”) and $750 million of 5.125% Senior Notes due 2036 (the “2036 Notes” and, together with the 2030 Notes, the “Notes”). The closing of the offering is expected to occur on August 21, 2025, subject to satisfaction of customary closing conditions.
The Company intends to use the net proceeds of this offering, together with the borrowings under its senior unsecured three-year delayed draw term loan facility that it expects to enter into and cash on hand, to finance the approximately $2.35 billion purchase price for the acquisition of AccuLynx (the “Acquisition”). The sale of the Notes is not conditioned upon the consummation of the Acquisition, which, if completed, will occur subsequent to the closing of the sale of the Notes.
Goldman Sachs & Co. LLC, BofA Securities, Inc. and Wells Fargo Securities, LLC are acting as joint book-running managers for the offering.
The Notes are being offered pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission on March 24, 2023. The offering of the Notes is made only by means of a prospectus supplement and accompanying prospectus. Copies may be obtained by contacting Goldman Sachs & Co. LLC, 200 West Street, New York, NY 10282, Attn: Prospectus Department, e-mail [email protected]; BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, e-mail [email protected]; or Wells Fargo Securities, LLC, 608 2nd Avenue South, Suite 1000, Minneapolis, MN 55402, Attn: WFS Customer Service, e-mail [email protected].
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the Notes, nor will there be any sale of the Notes in any jurisdiction in which such offer, solicitation, or sale would be unlawful. Any offer, solicitation or sale of the Notes will be made only by means of the prospectus supplement and the accompanying prospectus.
About Verisk
Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, extreme events, sustainability and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work and fosters an inclusive culture where all team members feel they belong.
Forward-Looking Statements
This press release contains forward-looking statements under the Private Securities Litigation Reform Act of 1995. These statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. For example, statements regarding the expected closing of the offering, the expected use of proceeds from the offering and the consummation of the Acquisition are forward-looking. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “target,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue” or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements, because they involve known and unknown risks, uncertainties, and other factors that are, in some cases, beyond the Company’s control and that could materially affect actual results, levels of activity, performance, or achievements.
Other factors that could materially affect actual results, levels of activity, performance, or achievements can be found in the Company’s quarterly reports on Form 10-Q, annual reports on Form 10-K, and current reports on Form 8-K filed with the Securities and Exchange Commission. If any of these risks or uncertainties materialize or if the Company’s underlying assumptions prove to be incorrect, actual results may vary significantly from what the Company projected. Any forward-looking statement in this release reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to the Company’s operations, results of operations, growth strategy, and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, whether as a result of new information, future events, or otherwise except as required by law.